Executive Chairman (ACCA, ISCA, SID)
Mr Leong is a Fellow of the Association of Chartered Certified Accountants (ACCA), Chartered Accountant of the Institute of Singapore Chartered Accountants (ISCA) and Member of the Singapore Institute of Directors (SID).
An Australian Permanent Resident, Mr Leong has considerable corporate, management and directorship experience in a broad range of functions and industries having undertaken several C-suite roles (CEO, COO, & CFO) in several private as well as listed companies. Mr Leong presently serves as a Non-Executive & Independent Director in several Singapore and Australian listed companies.
Professor Teoh Swee Hin
Non-Executive Director (B Eng (1st Hons), PhD Materials Engineering (Singapore))
Prof Teoh Swee Hin, is the President's Chair, School of Chemical and Biomedical Engineering (SCBE). He holds a joint appointment with the Lee Kong Chian School of Medicine (LKC Med) at Nanyang Technological University. His contribution is in the development and clinical translation of 3D bioresorbable scaffolds. Majoring in Materials Engineering (B. Eng -1st Class Hon and PhD, Monash University), his research journey focused at translating the materials research to biomedical benefits. He is a Fellow of the Academy of Engineers Singapore and Chief Engineer at Skin Research Institute of Singapore. His research focused on the study of mechanisms that promote cells proliferation and differentiation as a result of mechno induction through load bearing scaffolds for tissue regeneration and remodelling.
Prof Teoh's pioneering work on 3D printed scaffold led to him receiving the prestigious "Golden Innovation Award" at the Far East Economic Review, and the Institute of Engineers "Prestigious Engineering Achievement Award" in 2004. His group was ranked 1st in bone tissue engineering scaffolds in World Web of Science 2010. He was honoured with the Special Award for "Scientific Life-Time Achievement in Bone Tissue Engineering" at Bone-Tec 2015, Stuttgart. As a part of SG50 celebrations, he was featured as one of Singapore's profiled scientists in the book titled "Singapore's Scientific Pioneers".
Professor Teoh is presently the Chairman, Singapore Academy, Asia Regulatory Professional Association (ARPA). He sits on the board of editors for Tissue Engineering, Journal of Tissue Engineering and Regenerative Medicine, Journal of Mechanical Behaviour of Biomedical Materials, Journal of Oral & Maxillofacial Research and Proceedings of the Institution of Mechanical Engineers Part H: Journal of Engineering in Medicine.
Non-Executive Director (B.Com, CPA (Aust))
Mr Ow has over twenty years of international experience across multiple industries, including infrastructure, resources, property and fast-moving consumer goods. Mr Ow has held several accounting and management roles with large multinational corporations and is a Certified Practising Accountant (CPA), Australia. He is currently the Manager for Financial Business Partners at Perth Airport. Along with professional experience in investor relations, he also served as a Trustee Director on the Rio Tinto Staff Superannuation Fund (now merged with Equip Super).
Goh Khoon Seng
Chief Executive Officer (M.Eng (Mech) (Singapore))
Mr Goh's 30-year career spans both start-ups and global multinational corporations, with responsibilities in research & development, manufacturing, regional sales and marketing, and country management. Prior to joining Osteopore (OSX.ASX) Mr Goh spent over 20 years with Medtronic plc (Medtronic plc is the world's largest medical device company) and Edwards Lifesciences Asia in various senior management roles.
Mr Goh has been a Director of Osteopore Pte Ltd, since 2015 and has been involved in all aspects of the Company. He holds a Masters in Engineering (National University of Singapore) and post graduate diploma with Chartered Institute of Marketing (UK).
Chief Technology Officer (Ph.D. (Singapore))
Dr. Lim holds a PhD from Nanyang Technological University, Singapore. Prior to joining Osteopore (OSX.AX), Dr. Lim conducted research on biomaterials for tissue engineering and regenerative medicine, and developed material fabrication platforms. He published 14 articles in internationally peer-reviewed journals in that time. Dr. Lim joined Osteopore (OSX.AX) in December 2014, and has led Osteopore (OSX.AX) to important regulatory and quality milestones. In addition, Dr. Lim led the expansion of product and therapy portfolio, and contributed to the improvement in manufacturing efficiency.
Country Manager, Australia
Paul Turner is a widely experienced senior executive with Australasian and international scope in the medical device industry. He has 19 years of experience with Medtronic and Johnson & Johnson in several managerial positions.
His experiences involve introducing new technologies, surgical products, and procedures into Australasia. He also has direct experience in hospital segments including orthopaedic, vascular surgery, and cardiology.
Ms Deborah Ho is an Associate Member of the Governance Institute of Australia. Ms Ho has over seven years of experience in company secretarial, corporate compliance, and financial accounting matters and has acted as Company Secretary to a number of ASX-listed and private companies.
Mrs Davis has over 20 years' experience in accounting and ASX compliance. Beginning her career in Audit with Ernst & Young, she worked as a Financial Accountant and provided company secretarial services for a number of junior listed ASX companies. Mrs Davis has a Bachelor of Commerce (Accounting and Finance) Degree and is a Chartered Accountants Australia & New Zealand member.
Voon Shu Ning
Financial Controller (CPA (Aus))
Ms Voon holds a Bachelor of Accounting First Class Honours and is a member of CPA Australia.
Ms Voon has approximately 10 years of experience in the accounting field, and is currently responsible for all functions relating to finance, accounting and corporate reporting matters in Osteopore. Prior to joining Osteopore, Ms Voon worked in a SGX listed company, and previously was an audit supervisor in an audit firm.